LCAT has been extensively investigated as a potential biomarker for cancer, with studies indicating its association with invasive breast cancer as a common serum protein marker [41] and its decreased activity in patients with colorectal cancer [42]. This evidence concerns the gene LCAT and colorectal cancer.